CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −3,465.75 | $234.11 | $811K | 476,419 |
| 2026-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −2,209.79 | $234.11 | $517K | 474,209 |
| 2026-11-11 | Farrell Michael J. Chairman and CEO | Shares withheld for taxes | −2,435.84 | $234.11 | $570K | 471,774 |
| 2026-11-11 | Bloomer Aaron Chief Financial Officer | Shares withheld for taxes | −1,095.14 | $234.11 | $256K | 7,977 |
| 2026-11-11 | FARRELL PETER C Director | Shares withheld for taxes | −169.14 | $234.11 | $40K | 51,634 |
| 2026-11-11 | De Witte Jan Director | Shares withheld for taxes | −59.98 | $234.11 | $14K | 4,201 |
| 2026-11-11 | Gill Harjit Director | Shares withheld for taxes | −35.73 | $234.11 | $8K | 10,904 |
| 2026-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −547.47 | $234.11 | $128K | 11,813 |
| 2026-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −498.62 | $234.11 | $117K | 11,314 |
| 2026-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −724.41 | $234.11 | $170K | 10,590 |
| 2026-11-11 | Rider Michael J Global General Counsel | Shares withheld for taxes | −172.99 | $234.11 | $40K | 10,417 |
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Option exercise 10b5-1 | +683 | $146.34 | $100K | 480,486 |
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Option exercise 10b5-1 | +4,310 | $146.34 | $631K | 484,796 |
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,993 | $235.35 | $1.2M | 479,803 |
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Option exercise · ResMed Common Stock Options 10b5-1 | −683 | 4,310 | ||
| 2026-11-09 | Farrell Michael J. Chairman and CEO | Option exercise · ResMed Common Stock Options 10b5-1 | −4,310 | 0 | ||
| 2026-10-23 | Rider Michael J Global General Counsel | Sale 10b5-1 | −400 | $255.00 | $102K | 12,318 |
| 2026-10-07 | Farrell Michael J. Chairman and CEO | Option exercise 10b5-1 | +4,991 | $146.34 | $730K | 484,794 |
| 2026-10-07 | Farrell Michael J. Chairman and CEO | Sale 10b5-1 | −4,991 | $226.33 | $1.1M | 479,803 |
| 2026-10-07 | Farrell Michael J. Chairman and CEO | Option exercise · ResMed Common Stock Options 10b5-1 | −4,991 | 4,993 |
Page 1 of 19 · 366 trades